{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:08:53Z","timestamp":1759342133819,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.revmed.2004.04.008","type":"journal-article","created":{"date-parts":[[2004,4,23]],"date-time":"2004-04-23T05:53:46Z","timestamp":1082699626000},"page":"S22-S25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Traitement des polymyosites et dermatomyosites"],"prefix":"10.1016","volume":"25","author":[{"given":"P","family":"Ch\u00e9rin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2004.04.008_BIB1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis","volume":"362","author":"Dalakas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2004.04.008_BIB2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-199754010-00003","article-title":"Recognition and management of myositis","volume":"54","author":"Cherin","year":"1997","journal-title":"Drugs"},{"key":"10.1016\/j.revmed.2004.04.008_BIB3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1600-0404.1982.tb03087.x","article-title":"Polymyositis-treatment and prognosis: a study of 107\u00a0patients","volume":"65","author":"Henriksson","year":"1982","journal-title":"Act. Neurol. Scand."},{"key":"10.1016\/j.revmed.2004.04.008_BIB4","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V","article-title":"Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis","volume":"43","author":"Lundberg","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2004.04.008_BIB5","first-page":"621","article-title":"Long-term prognosis of patients with juvenile dermatomyositis initially treated with intravenous methylprednisolone pulse therapy","volume":"17","author":"Huang","year":"1999","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2004.04.008_BIB6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine for polymyositis. Long-term follow-up","volume":"24","author":"Bunch","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2004.04.008_BIB7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"Am. J. Med"},{"key":"10.1016\/j.revmed.2004.04.008_BIB8","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2169\/internalmedicine.39.428","article-title":"Successful combined therapy of cyclophosphamide and cyclosporine for acute exacerbated interstitial pneumonia associated with dermatomyositis","volume":"39","author":"Tanaka","year":"2000","journal-title":"Intern Med"},{"key":"10.1016\/j.revmed.2004.04.008_BIB9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(89)92456-2","article-title":"Cyclosporin in juvenile dermatomyositis","volume":"1","author":"Heckmatt","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2004.04.008_BIB10","first-page":"381","article-title":"Cyclosporine A as first choice therapy in dermatomyositis","volume":"21","author":"Grau","year":"1994","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.revmed.2004.04.008_BIB11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000051674","article-title":"Mycophenolate mofetil for dermatomyositis","volume":"202","author":"Tausche","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.revmed.2004.04.008_BIB12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-510X(01)00635-9","article-title":"FK506 suppressed the inflammatory change of EAM in SJL\/J mice","volume":"193","author":"Nemoto","year":"2001","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.revmed.2004.04.008_BIB13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0140-6736(90)91630-S","article-title":"Intravenous immunoglobulin for polymyositis and dermatomyositis","volume":"336","author":"Cherin","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2004.04.008_BIB14","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0002-9343(91)90009-M","article-title":"Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: An open study with 20\u00a0adult patients","volume":"91","author":"Cherin","year":"1991","journal-title":"Am. J. Med."},{"key":"10.1016\/j.revmed.2004.04.008_BIB15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/art.10053","article-title":"Results and long-term follow-up of intravenous immunoglobulin infusions in chronic refractory polymyositis: an open study with 35\u00a0adult patients","volume":"46","author":"Cherin","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2004.04.008_BIB16","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high dose intravenous immune globulin, infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2004.04.008_BIB17","first-page":"1092","article-title":"Intravenous gammaglobulin as first line therapy in polymyositis and dermatomyositis: a report of 11\u00a0cases","volume":"21","author":"Cherin","year":"1994","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.revmed.2004.04.008_BIB18","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/1529-0131(200010)43:10<2368::AID-ANR26>3.0.CO;2-8","article-title":"TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications","volume":"43","author":"Pachman","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"10.1016\/j.revmed.2004.04.008_BIB19","first-page":"S193","article-title":"Etanercept is effective in the treatment of polymyositis\u2013dermatomyositis which is refractory to conventional therapy including steroids and other disease modifying agents","volume":"43","author":"Amarillo","year":"2000","journal-title":"Arthritis Rheum"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866304001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:06:55Z","timestamp":1759334815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866304001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":19,"alternative-id":["S0248866304001328"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2004.04.008","relation":{},"ISSN":["0248-8663"],"issn-type":[{"type":"print","value":"0248-8663"}],"subject":[],"published":{"date-parts":[[2004,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traitement des polymyosites et dermatomyosites","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2004.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}